본문 바로가기
bar_progress

Text Size

Close

'Galaxy Watch7', Scheduled for Release in July This Year, Expected to Enable Blood Glucose Monitoring

Discussion with Samsung Health Advisory Board
Comprehensive Analysis of Health Data Including Blood Sugar
Early Disease Detection... Increased Potential for Behavior Change

Samsung Electronics' next-generation smartwatch, the 'Galaxy Watch7,' is expected to enable blood glucose monitoring through the application of artificial intelligence (AI) technology.


On the 25th, Samsung Newsroom reported that Heonsu Park, head of the Digital Health Team at the MX Division, met with Samsung Health advisory board members at Samsung Seoul Hospital on the 11th. At this meeting, participants discussed the future of the digital health industry and the role of AI-based wearable devices.

'Galaxy Watch7', Scheduled for Release in July This Year, Expected to Enable Blood Glucose Monitoring Samsung Electronics held a discussion on the 11th about the future of the digital health industry and the role of AI-based wearable devices. (From left) Heonsu Park, Head of Digital Health Team at Samsung Electronics MX Division; Dr. Michael Bloom, CEO of BeeKeeperAI; Dr. David Klonoff, Director of the Diabetes Research Institute at Mills Peninsula Medical Center; and Professor Myungjin Jung, Head of AI Research Center at Samsung Medical Center. [Source=Samsung Newsroom]

They agreed that AI-based wearables, by collecting users' health data, would provide actionable messages in daily life and contribute to disease prevention. Although they did not directly mention the Galaxy Watch7, scheduled for release in July, they anticipated that AI wearables would help in the early detection of diseases by collecting comprehensive health data such as blood glucose monitoring.


The advisory board members provide guidance on the development direction of Samsung's smart devices. Samsung titled this post "The Future of Healthcare, Finding Answers on Your Wrist," hinting that healthcare functions like blood glucose monitoring will be enhanced in the Galaxy Watch7.


Dr. David Klonoff, director of the Diabetes Research Institute at Mills Peninsula Medical Center, said, "Health indicators influence each other," adding, "Combining blood glucose data with sleep, blood pressure, and physical activity allows for a comprehensive understanding of health." He continued, "It can identify early signs of potential diseases such as diabetes," and predicted, "Wearables and AI will amplify these opportunities."


He advised, "I hope Samsung Electronics, based on continuous technological innovation, will utilize AI technology to advance health monitoring and promote actual behavioral changes in people, becoming an industry leader."


Dr. Michael Bloom, CEO of the medical analytics platform BeeKeeperAI, stated, "It is important that Samsung Electronics' products connect with users and induce positive behavioral changes based on an understanding of lifestyle habits," adding, "They have the potential not only to support individual users but also to care for the health of families, making future developments highly anticipated."


Professor Myungjin Jung, head of the AI Research Center at Samsung Medical Center, said that behavioral changes for a healthy daily life could also be encouraged with the help of family members. He stated, "Samsung Electronics, based on expertise and technological leadership, will greatly contribute to creating connections between people beyond device interconnectivity, enabling everyone to better understand their own and their family's health."


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top